Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
In vitro synergy between the CD4 down-modulating compound, CADA, and multiple anti-HIV drugs — Kurt Vermeire (2003) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
In vitro synergy between the CD4 down-modulating compound, CADA, and multiple anti-HIV drugs
Shared by
De Clercq Erik
KU Leuven
In vitro synergy between the CD4 down-modulating compound, CADA, and multiple anti-HIV drugs
Article
2003
en
Authors
+5 more
KV
Kurt Vermeire
SH
Sigrid Hatse
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2002
CADA, a specific CD4 down-modulating compound with potent anti-HIV activity
Dominique Schols
,
Kurt Vermeire
,
Sigrid Hatse
,
K Dey
,
M Samala
,
A Sodoma
,
De Clercq Erik
,
Thomas W. Bell
Article
2003
Anti-HIV activity profile of a highly specific CD4 receptor down-modulating compound
Kurt Vermeire
,
De Clercq Erik
,
K Dey
,
Thomas W. Bell
,
Dominique Schols
Article
2004
CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro
Kurt Vermeire
,
Katrien Princen
,
Sigrid Hatse
,
De Clercq Erik
,
K Dey
,
Thomas W. Bell
,
Dominique Schols
Article
2002
Correlation between the anti-HIV potency of CADA derivatives and their ability to down-modulate the CD4 receptor
Kurt Vermeire
,
Thomas W. Bell
,
De Clercq Erik
,
Dominique Schols
Article
2004
Synthesis of novel CADA compounds and their anti-HIV and CD4 down-modulation activities
S. Anugu
,
N.H. Duffy
,
K Dey
,
Jin Qiu
,
M Samala
,
A Sodoma
,
Thomas W. Bell
,
Kurt Vermeire
,
De Clercq Erik
,
Dominique Schols
Discussion(0)
No comments yet. Be the first to comment.